Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nel ASA Capital/Financing Update 2010

Jan 22, 2010

3670_rns_2010-01-22_a260cbe0-1848-4fc4-9913-71bb939dee43.html

Capital/Financing Update

Open in viewer

Opens in your device viewer

Approved prospectus

Oslo Børs has approved following prospectus:

Prospectus in connection with

Offering of minimum 1 and maximum 3,500,000 Offering

Shares in DiaGenic ASA at subscription price NOK 2.75

per Offering Share, with Subscription Rights issuable

to all shareholders as of 25 November 2009 except for

shareholders allocated shares in the Private

Placement resolved on 25 November 2009

Listing of up to 3,500,000 Subscription Rights for

trading on Oslo Børs from 25 January 2010 to and

including 8 February 2010 under the ticker

symbol "DIAG T"

Listing of up to 3,500,000 Offering Shares on Oslo

Børs

Subscription Period: 25 January 2010 at 9:00 (CET) to

8 February 2010 at 17:30 (CET)

Important notice:

The Subscription Rights must be used to subscribe for

Offering Shares or sold before the end of the

Subscription Period, as they thereafter will have no

value. Exercise of Subscription Rights listed on Oslo

Børs is to be made by use of the Subscription Form

attached to the Prospectus.

Managed by

Orion Securities AS and Argo Securities AS

The prospectus is available to the public at:

Diagenic ASA

Grenseveien 92

0663 Oslo

Phone: +47 23 24 89 50

[http://www.diagenic.com]

Argo Securities

Olav V's gt. 5

0161 Oslo

Phone: +47 24 14 74 00

[http://www.argosec.no]

Orion Securities

Rådhusgaten 25

0158 Oslo

Phone: +47 21 00 29 00

[http://www.securities.no]

21 January 20